Quantinno Capital Management LP Purchases 13,505 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Quantinno Capital Management LP increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 13.5% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 113,867 shares of the healthcare conglomerate’s stock after purchasing an additional 13,505 shares during the period. UnitedHealth Group accounts for 0.6% of Quantinno Capital Management LP’s investment portfolio, making the stock its 19th largest position. Quantinno Capital Management LP’s holdings in UnitedHealth Group were worth $57,601,000 as of its most recent filing with the SEC.

Other large investors have also recently modified their holdings of the company. NewSquare Capital LLC bought a new position in UnitedHealth Group in the fourth quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new position in shares of UnitedHealth Group during the 4th quarter worth $26,000. Hurley Capital LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $28,000. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $30,000. Finally, Aster Capital Management DIFC Ltd purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at about $30,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH opened at $311.23 on Wednesday. The stock has a 50-day moving average of $482.53 and a 200-day moving average of $519.28. UnitedHealth Group Incorporated has a one year low of $309.10 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market cap of $282.33 billion, a PE ratio of 20.08, a P/E/G ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the prior year, the company earned $6.91 EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.70%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is 35.18%.

Wall Street Analyst Weigh In

UNH has been the topic of several recent analyst reports. HSBC reissued a “hold” rating and issued a $490.00 target price on shares of UnitedHealth Group in a research note on Tuesday, April 22nd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. JPMorgan Chase & Co. reduced their price target on UnitedHealth Group from $652.00 to $525.00 and set an “overweight” rating on the stock in a research report on Thursday, April 24th. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Finally, Morgan Stanley reduced their price objective on UnitedHealth Group from $664.00 to $563.00 and set an “overweight” rating for the company in a research note on Tuesday, April 22nd. Four research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $596.86.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.